Pure Global

INMUNOENSAYO PARA LA DETERMINACIÓN DE AMILOIDE A SÉRICA - COFEPRIS Registration 1092R2022 SSA

Access comprehensive regulatory information for INMUNOENSAYO PARA LA DETERMINACIÓN DE AMILOIDE A SÉRICA (INMUNOENSAYO PARA LA DETERMINACIÓN DE AMILOIDE A SÉRICA) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1092R2022 SSA and manufactured by INSUMOS PARA LA SALUD, S.A. DE C.V.. The device was registered on October 20, 2022.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase I
1092R2022 SSA
INMUNOENSAYO PARA LA DETERMINACIÓN DE AMILOIDE A SÉRICA
COFEPRIS Analysis ID: 1092R2022 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
Clase I
Product Type (Spanish)
III. Agentes de diagnóstico
Product Type (English)
III. Agentes de diagnóstico
Trade Name (Spanish)
MAGLUMI® SERUM AMYLOID A (CLIA)
Trade Name (English)
MAGLUMI® SERUM AMYLOID A (CLIA)
Registration Information
Analysis ID
1092R2022 SSA
Registration Date
October 20, 2022
Manufacturer / Fabricante
Name (English)
INSUMOS PARA LA SALUD, S.A. DE C.V.